The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1035
September 11, 1998
View Complete Issue         Table of Contents 2019 
Gliadel Wafers for Treatment of Brain Tumors
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Gliadel Wafers for Treatment of Brain Tumors
September 11, 1998 (Issue: 1035)
A biodegradable polymer 'wafer' (Gliadel - Rh ne-Poulenc Rorer) impregnated with the alkylating agent carmustine (BCNU; Bicnu) has been marketed in the USA for local treatment of recurrent glioblastoma multiforme that requires re-operation. The ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Gliadel Wafers for Treatment of Brain Tumors
Article code: 1035c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.